Overview

Study to Compare Pharmacokinetics & Pharmacodynamics of Warfarin & Esmolol in the Absence & Presence of MEDI0382

Status:
Completed
Trial end date:
2018-04-09
Target enrollment:
Participant gender:
Summary
A Phase 1 study to evaluate the effect of MEDI0382 on PK and PD of warfarin and esmolol in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
MedImmune LLC
Treatments:
Esmolol
Warfarin